"This unique platform has the potential to overcome historical ... Sanofi has signed a series of deals to expand its R&D capabilities, fuelled in part by its blockbuster immunology brand Dupixent ...

Bayer is paying $1.5 billion upfront to claim ownership of Vividion's drug discovery platform, which uses chemoproteomics ... Vividion's in-house R&D efforts are still at the preclinical stage ...

The platform is powered by Veeva’s development cloud, which includes applications for clinical trial management, quality management and payments, among other R&D needs. Boehringer and Veeva ...

Albert’s AI-enabled platform transforms materials science R&D and accelerates chemical innovation Albert Invent, whose end-to-end R&D platform accelerates chemical innovation in materials ...

“Our independent in-house R&D began in 2009 and since then we have established our small molecule drug platform and biopharmaceutical platform,” Hui says. “Over the last four years, in ...

Dr. Lindner brings over three decades of experience in advancing innovation in diagnostics, previously as Global Head of R&D at Alere ... “A comprehensive platform that seamlessly integrates ...

as well as manufacturing innovations to improve efficiency – – Company will webcast its R&D Day event today at 9:00 a.m. E.T – “Alnylam is driving the field of RNAi therapeutics into the ...

An integrated and productive global research and development platform Henlius has built an integrated and efficient global R&D platform across three R&D facilities located in Shanghai and Taipei ...

OAKLAND, Calif.--(BUSINESS WIRE)--Albert Invent, whose end-to-end R&D platform accelerates chemical innovation in materials science through the application of AI and machine learning, today ...